Reviewing Livongo Health (LVGO) and The Competition

Livongo Health (NASDAQ: LVGO) is one of 59 publicly-traded companies in the “Computer programming, data processing, & other computer related” industry, but how does it contrast to its rivals? We will compare Livongo Health to related companies based on the strength of its earnings, profitability, dividends, analyst recommendations, institutional ownership, risk and valuation.

Insider and Institutional Ownership

35.6% of Livongo Health shares are held by institutional investors. Comparatively, 52.8% of shares of all “Computer programming, data processing, & other computer related” companies are held by institutional investors. 14.7% of shares of all “Computer programming, data processing, & other computer related” companies are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Analyst Recommendations

This is a summary of current ratings and recommmendations for Livongo Health and its rivals, as provided by MarketBeat.

Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Livongo Health 0 1 9 0 2.90
Livongo Health Competitors 960 3234 6436 319 2.56

Livongo Health currently has a consensus price target of $42.30, indicating a potential upside of 79.85%. As a group, “Computer programming, data processing, & other computer related” companies have a potential upside of 110.63%. Given Livongo Health’s rivals higher possible upside, analysts clearly believe Livongo Health has less favorable growth aspects than its rivals.


This table compares Livongo Health and its rivals’ net margins, return on equity and return on assets.

Net Margins Return on Equity Return on Assets
Livongo Health -32.34% -53.73% -17.10%
Livongo Health Competitors -4.05% -54.08% -3.57%

Valuation & Earnings

This table compares Livongo Health and its rivals revenue, earnings per share (EPS) and valuation.

Gross Revenue Net Income Price/Earnings Ratio
Livongo Health $170.20 million -$55.37 million -23.29
Livongo Health Competitors $8.32 billion $1.62 billion 44.83

Livongo Health’s rivals have higher revenue and earnings than Livongo Health. Livongo Health is trading at a lower price-to-earnings ratio than its rivals, indicating that it is currently more affordable than other companies in its industry.


Livongo Health rivals beat Livongo Health on 9 of the 12 factors compared.

About Livongo Health

Livongo Health, Inc. provides an integrated suite of solutions for the healthcare industry in North America. It solutions promote health behavior change based on real-time data capture supported by intuitive devices and insights driven by data science. The company offers a platform that provides cellular-connected devices, supplies, informed coaching, data science-enabled insights, and facilitates access to medications. Its products include Livongo for Diabetes, Livongo for Hypertension, Livongo for Prediabetes and Weight Management, and Livongo for Behavioral Health by myStrength. The company was formerly known as EosHealth, Inc. and changed its name to Livongo Health, Inc. in 2014. Livongo Health, Inc. was incorporated in 2008 and is headquartered in Mountain View, California.

Receive News & Ratings for Livongo Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Livongo Health and related companies with's FREE daily email newsletter.